Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin
Daschle Nomination For HHS Secretary Held Up in Senate Finance Committee; Corr Nominated Deputy HHS Secretary
FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products
FDA, Companies Fail To Collect COI Forms, Report Says
Sledge Elected ASCO President
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Prediction markets now allow betting on clinical trial results, FDA decisions
It’s a high-risk bet: Insider trading, equipoise, integrity of research, public trust are at stake - Trump plans a 200% tariff on imported generic drugs by 2029, raising fears of cancer drug shortages
“There is a reason why generics have been exempt from all the tariffs until now,” Brookings economist warns - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation
- FDA’s OCE publishes three final guidances to increase clinical trial enrollment









